2020
DOI: 10.1002/lary.29332
|View full text |Cite
|
Sign up to set email alerts
|

68Ga DOTANOC PET/CT Scan in Primary Juvenile Nasopharyngeal Angiofibroma ‐ A Pilot Study

Abstract: Objectives/Hypothesis Somatostatin receptors (SSTRs) are highly expressed in neuroendocrine tumors and is exploited for its imaging and treatment. SSTRs expression is also demonstrated in diverse benign and malignant tumor cell types and proliferating peri‐tumoral vessels. Similarly, Juvenile Nasopharyngeal Angiofibroma (JNA) expresses different SSTRs and may be utilized for its imaging and treatment using DOTA, 1‐Nal3‐octreotide (DOTANOC)‐PET/CT scan. Study Design Prospective cohort. Methods Nineteen clinico‐… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 31 publications
0
1
0
Order By: Relevance
“…1 Although structural imaging is the most commonly employed method of postoperative surveillance in JA, recently functional imaging with either prostate-specific membrane antigen or somatostatin tracer PET-CT has gained popularity. 2,3 Due to intraoperative bleeding and the difficulty in removing the disease completely, the rate of residual disease even after surgical treatment varies from 13% to 50%. As healing processes and postinflammatory scar enhance with contrast, late postoperative assessment of residual/ recurrent disease remains a major radiological challenge.…”
mentioning
confidence: 99%
“…1 Although structural imaging is the most commonly employed method of postoperative surveillance in JA, recently functional imaging with either prostate-specific membrane antigen or somatostatin tracer PET-CT has gained popularity. 2,3 Due to intraoperative bleeding and the difficulty in removing the disease completely, the rate of residual disease even after surgical treatment varies from 13% to 50%. As healing processes and postinflammatory scar enhance with contrast, late postoperative assessment of residual/ recurrent disease remains a major radiological challenge.…”
mentioning
confidence: 99%